Literature DB >> 12590209

Scott wiring for direct repair of lumbar spondylolysis.

Zahid Askar1, Douglas Wardlaw, Manjunath Koti.   

Abstract

STUDY
DESIGN: This is a retrospective study of consecutive patients who underwent Scott wiring for symptomatic lumbar spondylolysis using the MacNab criteria.
OBJECTIVE: The aim of the study was to assess the clinical outcome of the procedure after a mean follow-up period of more than 10 years. SUMMARY OF THE BACKGROUND DATA: Previous studies have shown this technique to be effective in the management of patients up to the age of 25 years who have symptomatic lumbar spondylolysis with or without a Grade 1 slip. No study has been published with regard to the long-term outcome of Scott wiring.
METHODS: Between 1986 and 1993, Scott wiring was performed for 15 patients younger than 25 years of age who had symptomatic lumbar spondylolysis. MacNab criteria were used to assess their pre- and postoperative status. A postal questionnaire was used to assess their clinical outcome. Their notes also were studied to find subsequent episodes of low back pain.
RESULTS: The postoperative questionnaires were returned by 14 patients. The mean follow-up period was 10.9 years. Of the 14 patients, 12 had a "good" or "excellent" result according to MacNab criteria. The two patients classified as "poor" required further procedures for continued low back pain.
CONCLUSIONS: The Scott wiring technique is recommended for the treatment of symptomatic lumbar spondylolysis in patients younger than 25 years because it gave "good" or "excellent" results in approximately 86% of the patients with a mean follow-up period of 10.9 years.

Entities:  

Mesh:

Year:  2003        PMID: 12590209     DOI: 10.1097/01.BRS.0000048496.55167.22

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  9 in total

1.  Direct screw fixation of the spondylolysis without fusion.

Authors:  Max Aebi
Journal:  Eur Spine J       Date:  2010-10       Impact factor: 3.134

Review 2.  A proposal for a surgical classification of pediatric lumbosacral spondylolisthesis based on current literature.

Authors:  Jean-Marc Mac-Thiong; Hubert Labelle
Journal:  Eur Spine J       Date:  2006-06-07       Impact factor: 3.134

3.  Direct repair for treatment of symptomatic spondylolysis and low-grade isthmic spondylolisthesis in young patients: no benefit in comparison to segmental fusion after a mean follow-up of 14.8 years.

Authors:  Dietrich Schlenzka; Ville Remes; Ilkka Helenius; Tommi Lamberg; Pekka Tervahartiala; Timo Yrjönen; Kaj Tallroth; Kalevi Osterman; Seppo Seitsalo; Mikko Poussa
Journal:  Eur Spine J       Date:  2006-02-07       Impact factor: 3.134

4.  Direct pars repair surgery using two different surgical methods : pedicle screw with universal hook system and direct pars screw fixation in symptomatic lumbar spondylosis patients.

Authors:  Myung-Hoon Shin; Kyeong-Sik Ryu; Nitesh Kumar Rathi; Chun-Kun Park
Journal:  J Korean Neurosurg Soc       Date:  2012-01-31

5.  Long-term results of the direct repair of spondylolisthesis.

Authors:  Fabrizio Giudici; L Minoia; M Archetti; A S Corriero; A Zagra
Journal:  Eur Spine J       Date:  2011-03-16       Impact factor: 3.134

Review 6.  A Review of Treatment for Acute and Chronic Pars Fractures in the Lumbar Spine.

Authors:  Alexander A Linton; Wellington K Hsu
Journal:  Curr Rev Musculoskelet Med       Date:  2022-05-02

7.  Application of a new anatomic hook-rod-pedicle screw system in young patients with lumbar spondylolysis: A pilot study.

Authors:  Duan-Ming Li; Yong-Chao Li; Wei Jiang; Bao-Gan Peng
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

8.  Direct repair of lumbar spondylolysis by Buck's technique.

Authors:  S Rajasekaran; M Subbiah; Ajoy Prasad Shetty
Journal:  Indian J Orthop       Date:  2011-03       Impact factor: 1.251

9.  Minimally invasive direct repair of bilateral lumbar spine pars defects in athletes.

Authors:  Gabriel A Widi; Seth K Williams; Allan D Levi
Journal:  Case Rep Med       Date:  2013-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.